Views & Analysis | Perspectives on pharma industry issues

Oncology

On GDF-15 neutralisation and cachexia, with CatalYm

As ESMO 2026 continues to get underway, pharmaphorum web editor Nicole Raleigh spoke with Scott Clarke, CEO of CatalYm.

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Articles

Editor’s Voice: January – welcome to 2013!

As we enter the beginning of January 2013, Hannah Blake takes a look at the content highlights from last year and reveals what pharmaphorum has in store for 2013. Welcome back everyone! I’d like to start by saying a big Happy New Year from pharmaphorum to all...

Articles

Rebooting healthcare branding in a new social and connected ...

Angel Gonzalez provides an overview of the recent annual Ideagoras event on innovation and social media in health. “The scarcest resource in the world is innovative people with ideas of their own". I recently read this tweet...

Articles

A year in review: my 2012 digital predictions (part 2)

Alex Butler continues to review his digital healthcare predictions for 2012, which he published with pharmaphorum in December last year. Even though this last year saw the annual Games for Health conference in Boston held for the eighth year, at the beginning of 2012...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital